tirzepatide 5.0 Eli Lilly sues companies selling alternative versions of its weight loss drug Lilly launches lower-price weight-loss drug

Add-on Therapy: A patient whose blood pressure is not adequately controlled with amlodipine (or another dihydropyridine calcium-channel blocker) alone or with valsartan (or another angiotensin II receptor blocker) alone may be switched to combination therapy with (Amlodipine and Valsartan)

This can help individuals eat less, leading to an average weight loss of 5% when combined with diet and exercise

First, one of the most striking things about this topic is how few innovations there are, from leading companies to startups to academia

Interprofessional collaboration in health care: lessons to be learned from competitive sports